Ixazomib Citrate Market Analysis, Type, Size, Trends, Key Players and Forecast 2024 to 2034
Ixazomib Citrate is an oral proteasome inhibitor used in the treatment of multiple myeloma, a type of blood cancer. It works by inhibiting the activity of proteasomes, which are protein complexes that play a critical role in maintaining cell function by degrading damaged or unneeded proteins. By inhibiting proteasomes, Ixazomib Citrate causes an accumulation of proteins within cancer cells, leading to cell death.
https://shubhamwemarket.blogsp....ot.com/2024/09/ixazo